Abnormality in hepatic lipids of a patient having taken coralgil, (hexestrol bis (beta-diethylaminoethyl ether)) for a long period.
D000368:Aged; D002784:Cholesterol / Q000378:metabolism; D002855:Chromatography, Thin Layer; D004048:Diethylamines / Q000009:adverse effects; D004983:Ethanolamines / Q000009:adverse effects; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D006589:Hexestrol / Q000009:adverse effects*; D006801:Humans; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008854:Microscopy, Electron; D010713:Phosphatidylcholines / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D013056:Spectrophotometry, Ultraviolet; D013107:Sphingolipids / Q000378:metabolism; D014665:Vasodilator Agents / Q000009:adverse effects*
D004048:Diethylamines; D004983:Ethanolamines; D005227:Fatty Acids; D010713:Phosphatidylcholines; D010716:Phosphatidylinositols; D010743:Phospholipids; D013107:Sphingolipids; D014665:Vasodilator Agents; D006589:Hexestrol; D002784:Cholesterol